Patients who went through the SEE program in Michigan were more likely to stick to their drug regimen and reported less ...

Patients with glaucoma who had low 24-hour systemic blood pressure were more likely to lose retinal nerve fiber layer despite well-controlled intraocular pressure.

Experts explain whether Lasik or lens implants affect your risk, and how a hair strand-like microshunt could reduce reliance on lifelong eye drops for patients.

In studies published so far, GLP-1 receptor agonists appear to be beneficial for the treatment of glaucoma, according to a review published in Cureus.“GLP-1 RAs exert both protective and adverse ...

Communicating to patients that they need to come to their annual checkup is important for eye doctors to convey to help treat their patients, says Ariana Levin, MD. Glaucoma is a disease that affects ...

Patient medication reminders via an EHR resulted in good uptake among patients at a tertiary glaucoma clinic, according to a study published in JAMA Ophthalmology. Researchers conducted a prospective, ...

Glaucoma, caused by high pressure within the eye, affects some 2.5 million Americans and is the nation's second leading cause of blindness. Optometrists screen for it during routine eye exams, often ...

Glaucoma is a devastating eye disease that currently affects more than 3 million Americans. By the year 2050, data shows the number of cases is projected to surge to more than 6 million cases. This is ...

Three studies presented at the American Glaucoma Society meeting demonstrated the potential benefit of NCX 470 in patients with glaucoma.NCX 470 (Nicox) is a nitric oxide-donating bimatoprost eye drop ...

Markers in the blood that predict whether glaucoma patients are at higher risk of continued loss of vision following conventional treatment have been identified by researchers. Markers in the blood ...